The author declares that they have no competing interests.
ES, the author, is responsible for the composition and draft of this manuscript and has read and approved the final manuscript.
Recently, a Surveillance Epidemiology and End Results (SEER) survey of melanoma patterns of care by the Mayo Clinic, Scottsdale showed remarkable deviations from best practice patterns throughout the country. The study, which analyzed the SEER records of 35,126 stage I to III cutaneous malignant melanoma patients treated from 2004 to 2006, showed that adherence to National Comprehensive Cancer Network (NCCN) therapeutic resection margins occurred in less than 36% of patients. Similarly, considerable variation in the quality of melanoma care in the United States when assessed using 26 quality indicators drawn by a panel of melanoma experts was independently reported. These observations underscore the significant lack of adherence to published best practice patterns reflected by the NCCN guidelines. The untoward effects of these variations in practice pattern can have an inordinate impact on the survival of melanoma patients in whom long term outcomes are affected by the adequacy of surgical management. Thin malignant melanoma is curable; however, thick or node positive melanoma is often incurable. This outcome is determined not only by the stage at presentation but by the use of best practice patterns as reflected in current NCCN cutaneous melanoma practice guidelines.
Wasif N, Gray RJ, Pockaj BA: Report card for compliance with NCCN guidelines in the surgical management of cutaneous melanoma across the United States: time for remedial classes?. ASCO Annual Meeting Proceedings. 2010, Abstract 8515
Balch CM, Milton GW, Shaw H, Soong S: Surgical Management of Primary Melanoma in Cutaneous Melanoma. 1985, J B Lippincott Co, 74-78.
Coit D: Imaging Guidelines for Melanoma. NCCN 16th Annual Conference. 2011, Hollywood, Florida
Caudle AS, Ross MI, Prieto VG, Warneke CL, Lee JE, Johnson MM, Gardner JM, Royal RE, Cormier JN, Lucci A, Gershenwald JE: Mitotic rate predicts sentinel node involvement in melanoma: Impact of the 7 th edition AJCC Melanoma Staging System. Ann Surg Oncol. 2010, Society of Surgical Oncology 63rd Annual Cancer Symposium. St Louis, MO, 2010, 17 (Suppl 1): S8-
Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M: Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastases: a randomized clinical trial. JAMA. 2011, 305: 569-575. 10.1001/jama.2011.90. CrossRefPubMed
Morton DL, Cochran AJ, Thompson JF, Elashoff R, Essner R, Glass EC, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Wang HJ, Multicenter Selective Lymphadenectomy Trial Group: Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005, 242: 302-311. discussion 311-313 PubMedCentralPubMed
Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Glass EC, Wang HJ, MSLT Group: Sentinel node biopsy or nodal observation in melanoma. N Eng J Med. 2006, 355: 1307-1317. 10.1056/NEJMoa060992. Erratum in N Engl J Med 2006, 355:1944 CrossRef
Ernstoff MS: Been there, not done that - melanoma in the age of molecular therapy. N Eng J Med. 2011, 364: 2547-2548. 10.1056/NEJMe1105792. CrossRef
- Adjunct primer for the use of national comprehensive cancer network guidelines for the surgical management of cutaneous malignant melanoma patients
- BioMed Central
Neu im Fachgebiet Chirurgie
e.Med Kampagnen-Visual, Mail Icon II